CCNB2 and COVID-19: The results of the hazards models showed that the expression of curcumol targets in COVID-19 and LUAD was significantly associated with the relative risk of survival [AURKA (p = 0.001, hazard ratio, 1.086–1.399); CDK1 (p < 0.001, hazard ratio, 1.099–1.401); CCNB1 (p < 0.001, hazard ratio, 1.144–1.499); CCNB2 (p < 0.001, hazard ratio, 1.089–1.388); CCNE1 (p = 0.012, hazard ratio, 1.032–1.283); CCNE2 (p = 0.026, hazard ratio, 1.019–1.341); TTK (p = 0.004, hazard ratio, 1.053–1.307)] in patients with LUAD (Figure 3A).